The Clinical Research Division’s collaborative programs focus on improving therapies for a number of hematologic malignancies, non-malignant diseases and solid tumor cancers. Our researchers strive to understand the genetic basis for these diseases and to translate that knowledge into new treatment approaches.
Our research extends to eliminating barriers to successful therapies such as acute complications during the transplant process or long-term effects after treatment. The goal is to ensure the translation of ideas into clinical trials that are well-constructed, carefully performed and appropriately analyzed.
[About the image: Meduloblastoma tumor from the cerebellum stained to differentiate subsets of neural cells (red) and MyoD (green).]
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.